Completed PHASE1 INTERVENTIONAL 2-arm NCT02504606

Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject

A Randomized, Open-label, Single Dose, 2-Treatment, 2-Period, 2-Way Crossover Study to Assess Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject

Sponsor: Huons Co., Ltd.

Conditions Hypertension

Interventions Amosartan Besylsartan

Updated 6 times since 2017 Last updated: Jul 20, 2015 Started: Sep 30, 2014 Primary completion: Oct 31, 2014 Completion: Oct 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02504606, this PHASE1 trial focuses on Hypertension and remains completed. Sponsored by Huons Co., Ltd., it has been updated 6 times since 2014, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Feb 2019 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Feb 2019 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Huons Co., Ltd.

Data source: Huons Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.